Myomo Inc (NYSE MKT:MYO) — Market Cap & Net Worth
Market Cap & Net Worth: Myomo Inc (MYO)
Myomo Inc (NYSE MKT:MYO) has a market capitalization of $32.84 Million ($32.84 Million) as of July 25, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #23423 globally and #5043 in its home market, demonstrating a 17.12% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Myomo Inc's stock price $1.04 by its total outstanding shares 38638653 (38.64 Million). See how much does Myomo Inc reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Myomo Inc Market Cap History: 2017 to 2026
Myomo Inc's market capitalization history from 2017 to 2026. Data shows change from $4.35 Billion to $40.18 Million (-45.09% CAGR).
Myomo Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Myomo Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.86x
Myomo Inc's market cap is 0.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $4.35 Billion | $1.56 Million | -$12.10 Million | 2788.47x | N/A |
| 2018 | $1.67 Billion | $2.44 Million | -$10.32 Million | 682.95x | N/A |
| 2019 | $348.68 Million | $3.84 Million | -$10.71 Million | 90.85x | N/A |
| 2020 | $260.04 Million | $7.58 Million | -$11.56 Million | 34.29x | N/A |
| 2021 | $264.48 Million | $13.86 Million | -$10.37 Million | 19.09x | N/A |
| 2022 | $19.76 Million | $15.56 Million | -$10.72 Million | 1.27x | N/A |
| 2023 | $193.58 Million | $19.24 Million | -$8.15 Million | 10.06x | N/A |
| 2024 | $248.83 Million | $32.55 Million | -$6.18 Million | 7.64x | N/A |
| 2025 | $35.16 Million | $40.93 Million | -$15.57 Million | 0.86x | N/A |
Competitor Companies of MYO by Market Capitalization
Companies near Myomo Inc in the global market cap rankings as of July 25, 2026.
Key companies related to Myomo Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $179.21 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #186 globally with a market cap of $126.38 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #232 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $179.21 Billion | $103.06 |
| #186 | Stryker Corporation | NYSE:SYK | $126.38 Billion | $330.25 |
| #232 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $83.21 |
Myomo Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, Myomo Inc's market cap moved from $4.35 Billion to $ 40.18 Million, with a yearly change of -45.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $40.18 Million | +14.29% |
| 2025 | $35.16 Million | -85.87% |
| 2024 | $248.83 Million | +28.54% |
| 2023 | $193.58 Million | +879.66% |
| 2022 | $19.76 Million | -92.53% |
| 2021 | $264.48 Million | +1.71% |
| 2020 | $260.04 Million | -25.42% |
| 2019 | $348.68 Million | -79.11% |
| 2018 | $1.67 Billion | -61.60% |
| 2017 | $4.35 Billion | -- |
End of Day Market Cap According to Different Sources
On Jul 25th, 2026 the market cap of Myomo Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.84 Million USD |
| MoneyControl | $32.84 Million USD |
| MarketWatch | $32.84 Million USD |
| marketcap.company | $32.84 Million USD |
| Reuters | $32.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more